Trial · NCT02229539
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Cycle 1 (Treatment Per Protocol) | STARTED | Doxepin | 78 | |
| Cycle 1 (Treatment Per Protocol) | STARTED | DLA (Diphenhydramine, Lidocaine and Antacid) | 76 | |
| Cycle 1 (Treatment Per Protocol) | STARTED | Placebo | 76 | |
| Cycle 1 (Treatment Per Protocol) | COMPLETED | Doxepin | 78 | |
| Cycle 1 (Treatment Per Protocol) | COMPLETED | DLA (Diphenhydramine, Lidocaine and Antacid) | 75 | |
| Cycle 1 (Treatment Per Protocol) | COMPLETED | Placebo | 74 | |
| Cycle 1 (Treatment Per Protocol) | NOT COMPLETED | Doxepin | 0 | |
| Cycle 1 (Treatment Per Protocol) | NOT COMPLETED | DLA (Diphenhydramine, Lidocaine and Antacid) | 1 | |
| Cycle 1 (Treatment Per Protocol) | NOT COMPLETED | Placebo | 2 | |
| Cycle 2 (Optional Continuation Phase) | STARTED | Doxepin | 35 | |
| Cycle 2 (Optional Continuation Phase) | STARTED | DLA (Diphenhydramine, Lidocaine and Antacid) | 38 | |
| Cycle 2 (Optional Continuation Phase) | STARTED | Placebo | 32 | |
| Cycle 2 (Optional Continuation Phase) | COMPLETED | Doxepin | 28 | |
| Cycle 2 (Optional Continuation Phase) | COMPLETED | DLA (Diphenhydramine, Lidocaine and Antacid) | 31 | |
| Cycle 2 (Optional Continuation Phase) | COMPLETED | Placebo | 22 | |
| Cycle 2 (Optional Continuation Phase) | NOT COMPLETED | Doxepin | 7 | |
| Cycle 2 (Optional Continuation Phase) | NOT COMPLETED | DLA (Diphenhydramine, Lidocaine and Antacid) | 7 | |
| Cycle 2 (Optional Continuation Phase) | NOT COMPLETED | Placebo | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02229539/flow